Scancell founder says the company is ready to commercialise novel medicines to counteract cancer. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksMED.L Regulatory News (MED)

  • There is currently no data for MED

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

ScanNav AI software featured on ITV

14 May 2018 07:00

RNS Number : 8913N
Medaphor Group PLC
14 May 2018
 

 

MedaPhor Group plc

("MedaPhor" or the "Group" or the "Company")

 

ScanNav AI software featured on ITV

 

MedaPhor Group plc (AIM: MED), the intelligent ultrasound software and simulation company, announces its artificial intelligence ("AI") based real-time image analysis software, ScanNav™ has featured on the ITV 'Wales This Week' programme.

 

ScanNav uses deep learning-based algorithms to automatically identify, grade and capture good ultrasound images to provide real-time guidance, assessment and audit of obstetric scanning. It is believed to be the first AI system to carry out an automated, real-time "peer review" of obstetric ultrasound images as the patient is scanned.

 

The technology is currently being piloted at the Fetal Medicine Department of St George's University Hospitals NHS Trust in London, UK.

 

Nicholas Sleep, Chief Technology Officer at MedaPhor, commented: "The initial feedback from the pilot of our ScanNav AI software in St George's Hospital, London has been very positive. After expanding the pilot over the coming months, we look forward to ScanNav being used more widely to improve ultrasound scanning for patients."

 

The feature is available to view on the Company website here: https://www.medaphor.com/tomorrows-ai-ultrasound-technology-is-here-scannav-debuts-on-itv-news/

 

 

Enquiries:

 

MedaPhor Group plc

www.medaphor.com

Stuart Gall, CEO

Ian Whittaker, COO

Tel: +44 (0)29 2075 6534

 

 

Cenkos Securities

Tel: +44 (0)20 7397 8900

Camilla Hume (Nominated Advisor)

 

Michael Johnson / Julian Morse (Corporate Broking)

 

 

 

Walbrook PR

Tel: +44 (0)20 7933 8780 or medaphor@walbrookpr.com

Paul McManus / Anna Dunphy

Mob: +44 (0)7980 541 893 / Mob: +44 (0)7876 741 001

   

 

 

About MedaPhor (www.investors.medaphor.com)

 

MedaPhor (AIM: MED), the intelligent ultrasound software and simulation company, develops artificial intelligence-based clinical image analysis software tools, augmented reality-based needle guidance software and advanced hi-fidelity haptic and manikin-based training simulators for medical practitioners.

 

Based in Cardiff and Oxford in the UK, Atlanta in the US and Hong Kong in Asia, MedaPhor operates two divisions:

 

Intelligent Ultrasound Simulation Division

 

Focuses on hi-fidelity ultrasound education and training through simulation. Its three main products are the ScanTrainer OBGYN and General Medical simulator training platform, the HeartWorks echocardiography simulator platform and the BodyWorks Eve Point of Care and Emergency Medicine Simulator. Over 500 MedaPhor simulators have been sold to over 300 medical institutions in over 30 countries around the world.

 

Intelligent Ultrasound Clinical Division

 

Focuses on augmented reality and deep-learning based algorithms to make ultrasound machines smarter and more accessible. Products in development include ScanNav and NeedleGuide. ScanNav uses machine-learning based algorithms to automatically identify, grade and capture good ultrasound images. NeedleGuide aims to simplify ultrasound-guided needling by using deep learning and augmented reality to provide the user with pathway guidance and automated tracking for a range of medical procedures.

 

Some products in the pipeline may require US FDA approval, as such this material should be considered informational only and does not constitute an offer to sell or infer claims or benefits.

 

 

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
NRALLFEAEDIVLIT
Date   Source Headline
24th Oct 20062:34 pmRNSDirectorate Change
23rd Oct 20062:14 pmRNSHolding(s) in Company
13th Oct 20062:31 pmRNSHolding(s) in Company
12th Oct 20069:44 amRNSHolding(s) in Company
10th Oct 200610:37 amRNSDirector/PDMR Shareholding
5th Oct 20069:52 amRNSHolding(s) in Company
4th Oct 200610:53 amRNSDirector/PDMR Shareholding
2nd Oct 20062:57 pmRNSResult of EGM
6th Sep 20067:03 amRNSPlacing
6th Sep 20067:03 amRNSInterim Results
31st Aug 20069:09 amRNSHolding(s) in Company
27th Jul 20067:00 amRNSBoard Appointment
15th Jun 20064:26 pmRNSHolding(s) in Company
14th Jun 20062:58 pmRNSHolding(s) in Company
23rd May 20063:30 pmRNSAGM Statement
27th Apr 200610:00 amRNSPublication of Annual Report
13th Mar 200611:56 amRNSBlocklisting Interim Review
22nd Feb 20067:01 amRNSFinal Results
8th Feb 200610:29 amRNSAppointment of Adviser
4th Jan 20063:25 pmRNSDirectorate Change
29th Dec 20057:00 amRNSShipment of First Product
25th Nov 200512:33 pmRNSDirector/PDMR Shareholding
26th Oct 20057:00 amRNSDirectorate Change
6th Oct 20054:21 pmRNSDirector/PDMR Shareholding
29th Sep 20057:03 amRNSInterim Results
9th Sep 200510:49 amRNSAdditional Listing
8th Sep 20053:52 pmRNSBlocklisting Interim Review
9th Aug 20054:57 pmRNSTrading Statement
12th Jul 20057:00 amRNSAppointment to the Board
24th Jun 20054:39 pmRNSDirector Shareholding
3rd Jun 20057:00 amRNSTrading Statement
15th Apr 20057:00 amRNSPreliminary Results
15th Apr 20057:00 amRNSDirectorate Change
21st Mar 20057:00 amRNSUMC Silicon Wafer Production
7th Mar 20052:55 pmRNSBlocklisting
21st Jan 20059:14 amRNSAdjustment to Options

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.